Form 4: Director Trades Class A Stock at Tempus AI
Statement of Changes in Beneficial Ownership
David R. Epstein, a Director at Tempus AI, Inc., reported a transaction involving Class A Common Stock on June 1, 2026, executed under a Rule 10b5-1 trading plan.
Summary
- Director David R. Epstein of Tempus AI, Inc. engaged in a transaction involving Class A Common Stock.
- The transaction occurred on June 1, 2026.
- Epstein acquired 250 shares of Class A Common Stock at a price of $49.40 per share.
- Following this transaction, Epstein beneficially owns 31,464 shares of Class A Common Stock.
- This transaction was executed as part of a Rule 10b5-1 trading plan established by the reporting person on August 27, 2024.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While director stock acquisitions can be positive, the execution under a pre-planned Rule 10b5-1 trading plan suggests a routine management of holdings rather than a strong conviction buy.
Positives
- The transaction was conducted under a pre-established Rule 10b5-1 trading plan, indicating a planned and structured approach to stock management.
- The acquisition of shares by a director can be interpreted as a positive signal of confidence in the company's future prospects.
Negatives
- The filing reports a disposition of securities, which could be perceived negatively by the market, although it was part of a pre-planned strategy.
Risks
- The primary risk associated with such filings is the potential for misinterpretation of director trades by the market, regardless of the underlying plan.
- The Rule 10b5-1 plan itself carries inherent risks if not properly structured and executed, potentially leading to insider trading allegations if not followed strictly.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. The Rule 10b5-1 plan implies a structured approach to future stock transactions, but specific outcomes are not detailed.
Management Comments
- "This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 27, 2024."
Industry Context
StockSavvy.ai notes that Form 4 filings, particularly those executed under Rule 10b5-1 plans, are common in the technology and biotechnology sectors where executive compensation often includes significant equity components. These plans are designed to allow insiders to buy or sell stock at predetermined times, mitigating concerns about insider trading.
Stakeholder Impact
- Shareholders: The acquisition by a director may be viewed positively, suggesting confidence in the company's value, but the pre-planned nature tempers strong sentiment.
- Employees: May see this as a sign of leadership's commitment to the company's long-term success.
- Management: Reinforces the established procedures for managing executive stock ownership.
Next Steps
- Continued monitoring of David R. Epstein's beneficial ownership of Tempus AI stock.
- Observation of any further transactions executed under the Rule 10b5-1 trading plan.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 06/01/2026 | Transaction Date for the acquisition of Class A Common Stock. |
| 06/03/2026 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
Form 4, SEC Filing, Insider Trading, Rule 10b5-1, Tempus AI, Class A Common Stock, Director Transaction, Beneficial Ownership, Stock Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.